Department of Pathology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea
1Division of Pulmonary and Critical Care Medicine, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea
© 2015 The Korean Society of Pathologists/The Korean Society for Cytopathology
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Characteristic | Pulmonary AdCC (n = 11) | SC (n = 20) | Non-pulmonary AdCC (n = 15) | p-value |
---|---|---|---|---|
Sex | ||||
Male | 6 (55) | 18 (90) | 6 (40) | .067a,b |
Female | 5 (45) | 2 (10) | 9 (60) | .462c,d |
Median age (range, yr) | 57 (42–75) | 68 (57–77) | 53 (32–76) | < .001a,e |
.168c,e | ||||
Smoking history | ||||
Smokerf | 5 (56)g | 19 (95) | 2 (14)g | .022a,b |
Never smokerh | 4 (44)g | 1 (5) | 12 (86)g | .066c,b |
Site | Trachea: 4 (36) | N1 LN: 15 (75) | Salivary gland: 12 (80) | - |
Bronchus: 5 (46) | N2 LN: 3 (15) | EAC: 2 (13) | ||
Mediastinal LN: 2 (18) | Unspecified: 2 (10) | Mouth floor: 1 (7) | ||
Stage | I: 2 (20)i | Limited: 11 (55) | I: 3 (20) | .667c,j |
II: 1 (10)i | Extensive: 9 (45) | II: 4 (27) | ||
III: 6 (60)i | III: 1 (7) | |||
IV: 1 (10)i | IV: 7 (46) | |||
Recurrence or metastasis | ||||
Present | 5 (45) | 2 (10) | 5 (33) | .067a,d |
Absent | 6 (55) | 18 (90) | 10 (67) | .689c,d |
Median follow up (range, mo) | 48 (3–177) | 7.5 (1–19) | 41 (4–70) | .003a,k |
.264c,e |
Values are presented as number (%) unless otherwise indicated.
AdCC, adenoid cystic carcinoma; SC, small cell carcinoma; LN, lymph node; EAC, external auditory canal.
ap-value between pulmonary AdCC and small cell carcinoma;
bFisher’s exact test;
cp-value between pulmonary AdCC and non-pulmonary AdCC;
dChi-square test;
eStudent’s t-test;
fSmoker group includes ex-smoker (stopped smoking for more than 365 days), habitual smoker (more than 1 tobacco product/day) and occasional smoker (less than 1 tobacco product/day);
gSmoking history was not able to obtain in two pulmonary AdCC cases and one non-pulmonary AdCC case;
hNever smokers had smoked less than 20 g of tobacco (equivalent to 100 or fewer cigarettes) in lifetime;
iStaging information was not available in one pulmonary AdCC case;
jLinear by linear association;
kMann-Whitney test.
Feature | Pulmonary AdCC (n=11) | SC (n=20) | Non-pulmonary AdCC (n=15) | p-value (pulmonary AdCC/SC) | p-value (pulmonary AdCC/non-pulmonary AdCC) |
---|---|---|---|---|---|
Histologic pattern | |||||
AdCC, tubular pattern | 0/11 | - | 2/14 | - | .167a |
AdCC, cribriform pattern | 9/11 | - | 11/14 | ||
AdCC, solid pattern | 2/11 | - | 1/14 | ||
Cytologic findings | |||||
Specimen cellularity | .031a | .138a | |||
3 | 3/11 | 13/20 | 9/15 | ||
2 | 4/11 | 5/20 | 4/15 | ||
1 | 4/11 | 2/20 | 2/15 | ||
Small cell | 5/11 | 20/20 | 13/15 | .001b | .038b |
Cellular uniformity | 9/10 | 2/20 | 12/15 | < .001b | .626b |
Coarse chromatin | 6/11 | 19/20 | 7/15 | .013b | .691c |
Hyperchromasia | 5/11 | 20/20 | 12/15 | .001b | .103b |
Distinct nucleolus | 6/11 | 0/20 | 10/15 | .001b | .689b |
Frequent molding | 0/11 | 19/20 | 1/15 | < .001b | .577b |
Granular cytoplasm | 8/11 | 0/20 | 12/15 | < .001b | .509b |
Distinct cell border | 3/11 | 0/20 | 4/15 | .037b | .655b |
Organoid cluster | 8/8 | 2/20 | 12/15 | < .001b | .526b |
Sheet formation | 4/9 | 13/20 | 14/15 | .422b | .015b |
Irregular cluster border | 4/9 | 20/20 | 7/15 | .001b | .625b |
Hyaline globule | 4/11 | 0/20 | 12/15 | .010b | .043b |
Hyaline BM material | 3/11 | 0/20 | 5/15 | .037b | .543b |
Cell necrosis/apoptotic body | 0/11 | 18/20 | 2/15 | < .001b | .492b |
Necrotic background | 2/11 | 16/20 | 2/15 | .002b | .574b |
AdCC, adenoid cystic carcinoma; SC, small cell carcinoma; p-value (pulmonary AdCC/SC), p-value between pulmonary AdCC and small cell carcinoma; p-value (pulmonary AdCC/non-pulmonary AdCC), p-value between pulmonary AdCC and non-pulmonary AdCC; BM, basement membrane.
aLinear by linear association;
bFisher exact test;
cChi-square test.
Case No. | Sex | Age (yr) | Specimen | Site | Cytologic diagnosis | Histologic pattern | Bronchoscopic finding | Stage | TNM | Progression | Follow-up period (mo) |
---|---|---|---|---|---|---|---|---|---|---|---|
1 | M | 42 | FNA | LN, 1R | Metastatic carcinoma from trachea | Solid | Bronchial narrowing | IIIA | T1bN2M0 | NED | 3 |
2 | F | 47 | BW | Lt main bronchus | PFMC | Solid | Endobronchial tumor infiltration | IB | T2aN0M0 | NED | 8 |
3 | M | 52 | FNA | LN, 7 | Metastatic AdCC from lung | Cribriform | Bronchial obstruction | IIIA | T1bN2M0 | Metastasis to LN | 54 |
4 | F | 61 | FNA | Trachea | AdCC cannot be excluded | Cribriform | NA | IIIA | T4N0M0 | Metastasis to lung | 34 |
5 | M | 57 | BW | Rt lower bronchus | A nest of atypical cells | Cribriform | Bronchial obstructing mass | IIIA | T2aN2M0 | NED | 108 |
6 | M | 65 | BW | Carina | Atypical cells | Cribriform | Tracheal obstruction | IV | T2aN0M1 | NED | 52 |
7 | F | 75 | BW | Lt main bronchus | Suspicious malignancy | Cribriform | Bronchial narrowing | NA | NA | Local recurrence | 48 |
8 | M | 60 | BW | Rt upper bronchus | Suspicious malignancy | Cribriform | Bronchial obstruction | IIB | T3N0M0 | Local recurrence | 177 |
9 | M | 53 | BW | Trachea | AdCC cannot be excluded | Cribriform | Tracheal mass | IA | T1bN0M0 | Local recurrence | 123 |
10 | F | 58 | BW | Rt main bronchus | PFMC | Cribriform | Bronchial obstructing mass | IIIA | T4N0M0 | NED | 6 |
11 | F | 55 | FNA | Trachea | AdCC versus epithelial myoepithelial carcinoma | Cribriform | NA | IIIA | T4N0M0 | NED | 17 |
Characteristic | Pulmonary AdCC (n = 11) | SC (n = 20) | Non-pulmonary AdCC (n = 15) | p-value |
---|---|---|---|---|
Sex | ||||
Male | 6 (55) | 18 (90) | 6 (40) | .067 |
Female | 5 (45) | 2 (10) | 9 (60) | .462 |
Median age (range, yr) | 57 (42–75) | 68 (57–77) | 53 (32–76) | < .001 |
.168 |
||||
Smoking history | ||||
Smoker |
5 (56) |
19 (95) | 2 (14) |
.022 |
Never smoker |
4 (44) |
1 (5) | 12 (86) |
.066 |
Site | Trachea: 4 (36) | N1 LN: 15 (75) | Salivary gland: 12 (80) | - |
Bronchus: 5 (46) | N2 LN: 3 (15) | EAC: 2 (13) | ||
Mediastinal LN: 2 (18) | Unspecified: 2 (10) | Mouth floor: 1 (7) | ||
Stage | I: 2 (20) |
Limited: 11 (55) | I: 3 (20) | .667 |
II: 1 (10) |
Extensive: 9 (45) | II: 4 (27) | ||
III: 6 (60) |
III: 1 (7) | |||
IV: 1 (10) |
IV: 7 (46) | |||
Recurrence or metastasis | ||||
Present | 5 (45) | 2 (10) | 5 (33) | .067 |
Absent | 6 (55) | 18 (90) | 10 (67) | .689 |
Median follow up (range, mo) | 48 (3–177) | 7.5 (1–19) | 41 (4–70) | .003 |
.264 |
Feature | Pulmonary AdCC (n=11) | SC (n=20) | Non-pulmonary AdCC (n=15) | p-value (pulmonary AdCC/SC) | p-value (pulmonary AdCC/non-pulmonary AdCC) |
---|---|---|---|---|---|
Histologic pattern | |||||
AdCC, tubular pattern | 0/11 | - | 2/14 | - | .167 |
AdCC, cribriform pattern | 9/11 | - | 11/14 | ||
AdCC, solid pattern | 2/11 | - | 1/14 | ||
Cytologic findings | |||||
Specimen cellularity | .031 |
.138 |
|||
3 | 3/11 | 13/20 | 9/15 | ||
2 | 4/11 | 5/20 | 4/15 | ||
1 | 4/11 | 2/20 | 2/15 | ||
Small cell | 5/11 | 20/20 | 13/15 | .001 |
.038 |
Cellular uniformity | 9/10 | 2/20 | 12/15 | < .001 |
.626 |
Coarse chromatin | 6/11 | 19/20 | 7/15 | .013 |
.691 |
Hyperchromasia | 5/11 | 20/20 | 12/15 | .001 |
.103 |
Distinct nucleolus | 6/11 | 0/20 | 10/15 | .001 |
.689 |
Frequent molding | 0/11 | 19/20 | 1/15 | < .001 |
.577 |
Granular cytoplasm | 8/11 | 0/20 | 12/15 | < .001 |
.509 |
Distinct cell border | 3/11 | 0/20 | 4/15 | .037 |
.655 |
Organoid cluster | 8/8 | 2/20 | 12/15 | < .001 |
.526 |
Sheet formation | 4/9 | 13/20 | 14/15 | .422 |
.015 |
Irregular cluster border | 4/9 | 20/20 | 7/15 | .001 |
.625 |
Hyaline globule | 4/11 | 0/20 | 12/15 | .010 |
.043 |
Hyaline BM material | 3/11 | 0/20 | 5/15 | .037 |
.543 |
Cell necrosis/apoptotic body | 0/11 | 18/20 | 2/15 | < .001 |
.492 |
Necrotic background | 2/11 | 16/20 | 2/15 | .002 |
.574 |
M, male; FNA, fine-needle aspiration; LN, lymph node; NED, no evidence of disease; F, female; BW, bronchial washing; Lt, left; PFMC, positive for malignant cells; AdCC, adenoid cystic carcinoma; NA, not available; Rt, right.
Values are presented as number (%) unless otherwise indicated. AdCC, adenoid cystic carcinoma; SC, small cell carcinoma; LN, lymph node; EAC, external auditory canal. p-value between pulmonary AdCC and small cell carcinoma; Fisher’s exact test; p-value between pulmonary AdCC and non-pulmonary AdCC; Chi-square test; Student’s t-test; Smoker group includes ex-smoker (stopped smoking for more than 365 days), habitual smoker (more than 1 tobacco product/day) and occasional smoker (less than 1 tobacco product/day); Smoking history was not able to obtain in two pulmonary AdCC cases and one non-pulmonary AdCC case; Never smokers had smoked less than 20 g of tobacco (equivalent to 100 or fewer cigarettes) in lifetime; Staging information was not available in one pulmonary AdCC case; Linear by linear association; Mann-Whitney test.
AdCC, adenoid cystic carcinoma; SC, small cell carcinoma; p-value (pulmonary AdCC/SC), p-value between pulmonary AdCC and small cell carcinoma; p-value (pulmonary AdCC/non-pulmonary AdCC), p-value between pulmonary AdCC and non-pulmonary AdCC; BM, basement membrane. Linear by linear association; Fisher exact test; Chi-square test.